Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
Latest reported TRAW revenue for 2025-09-30 was $2.8M. Net income was $16.6M. Revenue was up 2.1% from 2025-06-30 to 2025-09-30. TRAW currently screens at market cap $12.1M.
Use this TRAW page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TRAW quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TRAW SEC filings page. Lician reads the product cache first so this HTML stays unique to Traws Pharma Inc even when a live quote feed is slow.
Latest cached year on this hub. Full TRAW income, balance, and cash tables.